U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C28H24N4O2
Molecular Weight 448.5158
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of TARAZEPIDE

SMILES

CN1C2=C(C=CC=C2)C(=N[C@H](NC(=O)C3=CC4=C5N3CCCC5=CC=C4)C1=O)C6=CC=CC=C6

InChI

InChIKey=CZPILLBHPRAPCB-AREMUKBSSA-N
InChI=1S/C28H24N4O2/c1-31-22-15-6-5-14-21(22)24(18-9-3-2-4-10-18)29-26(28(31)34)30-27(33)23-17-20-12-7-11-19-13-8-16-32(23)25(19)20/h2-7,9-12,14-15,17,26H,8,13,16H2,1H3,(H,30,33)/t26-/m1/s1

HIDE SMILES / InChI

Molecular Formula C28H24N4O2
Molecular Weight 448.5158
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Tarazepide is a cholecystokinin-A receptor (CCK-A) receptor antagonist that was studied as an antispasmodic agent. However, information about the current use of this drug is not available.

Approval Year

PubMed

PubMed

TitleDatePubMed
Melatonin and its precursor, L-tryptophan: influence on pancreatic amylase secretion in vivo and in vitro.
2004-04
CCK regulates pancreatic enzyme secretion via short duodenal-pancreatic reflexes in pigs.
2003-02
Nanosuspensions as a new approach for the formulation for the poorly soluble drug tarazepide.
2000-03-10
Effects of intraduodenal administration of tarazepide on pancreatic secretion and duodenal EMG in neonatal calves.
1998-11-30
Patents

Patents

Substance Class Chemical
Created
by admin
on Mon Mar 31 18:16:18 GMT 2025
Edited
by admin
on Mon Mar 31 18:16:18 GMT 2025
Record UNII
RK2972YZ2U
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
tarazepide [INN]
Preferred Name English
TARAZEPIDE
INN  
INN  
Official Name English
4H-Pyrrolo[3,2,1-ij]quinoline-2-carboxamide, N-[(3S)-2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-5,6-dihydro-
Systematic Name English
N-[(3S)-2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinoline-2-carboxamide
Systematic Name English
Classification Tree Code System Code
NCI_THESAURUS C547
Created by admin on Mon Mar 31 18:16:18 GMT 2025 , Edited by admin on Mon Mar 31 18:16:18 GMT 2025
Code System Code Type Description
EVMPD
SUB10832MIG
Created by admin on Mon Mar 31 18:16:18 GMT 2025 , Edited by admin on Mon Mar 31 18:16:18 GMT 2025
PRIMARY
NCI_THESAURUS
C76465
Created by admin on Mon Mar 31 18:16:18 GMT 2025 , Edited by admin on Mon Mar 31 18:16:18 GMT 2025
PRIMARY
DRUG BANK
DB06435
Created by admin on Mon Mar 31 18:16:18 GMT 2025 , Edited by admin on Mon Mar 31 18:16:18 GMT 2025
PRIMARY
EPA CompTox
DTXSID101350940
Created by admin on Mon Mar 31 18:16:18 GMT 2025 , Edited by admin on Mon Mar 31 18:16:18 GMT 2025
PRIMARY
FDA UNII
RK2972YZ2U
Created by admin on Mon Mar 31 18:16:18 GMT 2025 , Edited by admin on Mon Mar 31 18:16:18 GMT 2025
PRIMARY
INN
7008
Created by admin on Mon Mar 31 18:16:18 GMT 2025 , Edited by admin on Mon Mar 31 18:16:18 GMT 2025
PRIMARY
PUBCHEM
10343641
Created by admin on Mon Mar 31 18:16:18 GMT 2025 , Edited by admin on Mon Mar 31 18:16:18 GMT 2025
PRIMARY
CAS
141374-81-4
Created by admin on Mon Mar 31 18:16:18 GMT 2025 , Edited by admin on Mon Mar 31 18:16:18 GMT 2025
PRIMARY
SMS_ID
100000082405
Created by admin on Mon Mar 31 18:16:18 GMT 2025 , Edited by admin on Mon Mar 31 18:16:18 GMT 2025
PRIMARY
MESH
C118031
Created by admin on Mon Mar 31 18:16:18 GMT 2025 , Edited by admin on Mon Mar 31 18:16:18 GMT 2025
PRIMARY
ChEMBL
CHEMBL1742455
Created by admin on Mon Mar 31 18:16:18 GMT 2025 , Edited by admin on Mon Mar 31 18:16:18 GMT 2025
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
Related Record Type Details
ACTIVE MOIETY